Uncertainty of Spanish Tobacco Regulations: PMI Calls for Clarity

Mar.31.2025
Uncertainty of Spanish Tobacco Regulations: PMI Calls for Clarity
PMI urges Spain to clarify tobacco regulations, differentiate traditional cigarettes from new products, emphasizing harm reduction and regulation effectiveness.

Key points:

The tobacco regulations in Spain are uncertain, prompting PMI to call for a clear regulatory framework to distinguish between traditional cigarettes and new tobacco products.

It is more effective to strictly regulate traditional cigarettes than to ban new products. Sweden's successful case shows that promoting alternative products can effectively reduce smoking rates.

PMI aims to strengthen traditional cigarette restrictions and promote the transition to safer alternatives in order to achieve smoking reduction goals.


According to a report by The Objective on March 30th, Spain is currently facing uncertainty regarding tobacco regulations, particularly in the regulation of new consumption methods such as e-cigarettes and heated tobacco devices.

 

Philip Morris International (PMI) emphasizes the need for a clear regulatory framework to distinguish between traditional cigarettes and new tobacco products. Daniel Cuevas, the CEO of PMI's Spanish branch, highlights that the health risks of non-combustible alternatives are significantly lower than those of traditional cigarettes.

 

Our main concern is the confusion and lack of distinction between different products. Non-combustible alternatives must be treated differently, as their harm is significantly lower than traditional cigarettes. We believe that society and adult smokers should have access to all available information without ideological biases. Research from organizations such as the US FDA and the Finnish Ministry of Health shows that non-combustible products can significantly reduce harm compared to traditional cigarettes.

 

However, currently the nine million smokers in Spain may continue to use traditional cigarettes if not properly guided.

 

Cuevas believes that any product containing nicotine should be strictly regulated, including restrictions on adult purchases, sales only in tobacco shops, clear tax policies, and advertising limitations for adult smokers. However, the current policy of the Spanish Ministry of Health is not just regulation, but instead considering a complete ban on these products. This approach is unreasonable. Instead of banning proven effective alternatives, it would be more sensible to enhance regulation of traditional cigarettes, as they are the most harmful products.

 

Cuevas expressed that prohibition strategies are not as effective as strict regulation. He mentioned Sweden's success, where smoking rates have dropped to below 5% and lung cancer cases have significantly decreased through the promotion of non-combustible alternatives. He firmly believes that without a rational regulatory framework, prohibiting smoke-free alternatives may isolate Spain globally.

 

Regarding market investments, Cuevas  stated that the current policy uncertainty has already affected the investment pace of PMI in Spain. They are committed to investing in heated tobacco products and in promising technological innovations. However, he stressed, "If there were a clear and predictable regulatory environment, we could make more investments at a faster rate.

 

Cuevas called for strengthening restrictions on traditional cigarettes and urged a transition to safer alternatives. He reiterated that PMI will continue to actively advocate for reducing tobacco use within the framework of regulations and promote a rational attitude towards smoke-free alternatives across society. The success in Sweden has given them confidence, but Spain will need to adjust current measures if it wants to achieve similar goals.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
British American Tobacco (BAT) reaffirmed its 2026 guidance while announcing a £1.3 billion (approximately USD 1.65 billion) share buyback for FY26. The company expects around 2% growth in revenue and adjusted profit from operations for FY25. Accelerating New Category growth, driven by Velo Plus and improving U.S. Vuse performance, is expected to deliver double-digit H2 revenue growth.
Dec.09 by 2FIRSTS.ai
South Korea’s Parliament Reconsiders Bill to Regulate Synthetic Nicotine as Tobacco
South Korea’s Parliament Reconsiders Bill to Regulate Synthetic Nicotine as Tobacco
South Korea’s National Assembly is once again reviewing a bill to classify synthetic nicotine as a tobacco product under the Tobacco Business Act. The proposal aims to close regulatory loopholes that allow untaxed, unregulated nicotine liquids — often used by minors — to circulate freely. Lawmakers expect the bill to pass during the current session amid growing public and civic pressure.
Nov.26 by 2FIRSTS.ai
Azerbaijan Considers Comprehensive Ban on E-cigarettes
Azerbaijan Considers Comprehensive Ban on E-cigarettes
Azerbaijan is advancing legislative amendments to prohibit the circulation of electronic cigarettes and their components. The proposed changes, discussed at a joint meeting of several parliamentary committees, aim to ban the import, export, production, storage, wholesale and retail sale, and use of e-cigarettes.
Dec.17 by 2FIRSTS.ai
U.S. 25 Attorneys General Urge Shopify to Block Illegal E-Cigarette Sales
U.S. 25 Attorneys General Urge Shopify to Block Illegal E-Cigarette Sales
California Attorney General Rob Bonta and the City of New York co-led a bipartisan coalition of 25 attorneys general in urging Shopify Inc. to take stronger measures against merchants selling illegal e-cigarettes and other tobacco products through its platform. The letter calls for cooperation between Shopify and U.S. states to address the persistent sale of unapproved vaping products.
Nov.25 by 2FIRSTS.ai
Alaska Settles with Juul and Altria for $7.8 Million After Five-Year Lawsuit
Alaska Settles with Juul and Altria for $7.8 Million After Five-Year Lawsuit
The State of Alaska has reached a $7.8 million settlement with e-cigarette maker Juul and its investor Altria, concluding a five-year lawsuit alleging the companies targeted Alaskan youth with nicotine products.
Dec.08 by 2FIRSTS.ai
Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade
Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade
California-based vape manufacturer Schwartz E-Liquid (USA Vape Lab) has sued the U.S. Food and Drug Administration (FDA) in federal court, alleging the agency unlawfully failed to issue a decision on its premarket application for flavored e-cigarette products for more than five years. The company is seeking a court order compelling the FDA to act within 90 days.
Nov.26 by 2FIRSTS.ai